Holm NT, Abreo F, Johnson LW, Li BDL, Chu QD. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Research and Treatment. 2008 Feb 13;113(2):293–9. doi: 10.1007/s10549-008-9921-8.
Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)